The latest price target for CareDx (NASDAQ:CDNA) was reported by Wells Fargo on December 15, 2025. The analyst firm set a price target for $18.00 expecting CDNA to fall to within 12 months (a possible -9.59% downside). 14 analyst firms have reported ratings in the last year.

The latest analyst rating for CareDx (NASDAQ:CDNA) was provided by Wells Fargo, and CareDx maintained their equal-weight rating.

The last upgrade for CareDx Inc happened on January 15, 2025 when Wells Fargo raised their price target to $24. Wells Fargo previously had an underweight for CareDx Inc.

The last downgrade for CareDx Inc happened on May 13, 2024 when Raymond James changed their price target from N/A to N/A for CareDx Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareDx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareDx was filed on December 15, 2025 so you should expect the next rating to be made available sometime around December 15, 2026.

While ratings are subjective and will change, the latest CareDx (CDNA) rating was a maintained with a price target of $14.00 to $18.00. The current price CareDx (CDNA) is trading at is $19.91, which is out of the analyst’s predicted range.